Ledger.Open graph →
SEC Form D · filed August 6, 2021

CytoImmune Therapeutics, Inc

Offering
$100.3M
Sold
$36.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monrovia, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Will Rosellini · Monrovia, CAExecWill Rosellini · New York, NYExecRichard T. Santulli · Monrovia, CAExecDouglas T. Williams · Monrovia, CADirectorKinam T. Hong · Monrovia, CADirectorAleksey Krylov · Monrovia, CAExecWill Rosellini · Monrovia, CAExecRichard T. Santulli · Monrovia, CAExecDouglas T. Williams · Monrovia, CADirectorKinam T. Hong · Monrovia, CADirectorAleksey Krylov · Monrovia, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗